Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney

Journal of the American Society of Nephrology

Volumn 7, Issue 5, 1996, Pages 653-660

  Lapinski, Radoslaw ^a   Perico, Norberto ^a,b   Remuzzi, Andrea ^a,b   Sangalli, Fabio ^a   Benigni, Ariela ^a   Remuzzi, Giuseppe ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Angiotensin receptor blockade; Ficoll clearance; Proteinuria; Size selective properties

Indexed keywords

ALBUMIN; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; FICOLL; IRBESARTAN;

ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CONTROLLED STUDY; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; ISOLATED KIDNEY; KIDNEY PERFUSION; MACROMOLECULE; MALE; MOLECULAR SIZE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SURFACE CHARGE; URINE VOLUME;

EID: 0030368533     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985;76: 612-619.
2. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
3. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986;77:1993-2000.
4. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990;85:541-549.
5. Hommel E, Parving HH, Mathiesen E, Edsberg B, Damkjaer M, Giese J: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 1986;293:467-470.
6. Bjorck S, Nyberg G, Mulec H, Ganerus G, Herlitz H, Aurell M: Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986;293:471-474.
7. Marre M, Le Blanc H, Suarez L: Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 1987;294:1448-1452.
8. Parving HH, Hommel E, Smidt UM: Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. Br Med J 1988;297:1086-1091.
9. Anderson S, Rennke G, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989;36:526-536.
10. Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G: Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage. Exp Nephrol 1994;2:220-228.
11. Remuzzi A, Imberti O, Puntorieri S, et al.: Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats. Am J Physiol 1994;267:F1034-F1044.
12. Lewis EJ, Hunsicker LG, Bain RP, Ronde RD, for the Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
13. Hannedouche T, Landais P, Goldfarb B, et al.: Randomised controlled trial of enalapril and β blockers in non-diabetic chronic renal failure. Br Med J 1994;309:833-837.
14. Bjorck S, Mulec H, Johnsen SA, Nyberg G, Aurell M: Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. Br Med J 1990;300: 904-907.
15. Lebovitz HE, Wiegmann TB, Cnaan A, et al.: Renal protective effects of enalapril in hypertensive NIDDM: Role of baseline albuminuria. Kidney Int 1994;45(Suppl 45):S150-S155.
16. Rippe B, Haraldsson B: Transport of macromolecules across microvascular walls: The two-pore theory. Pharmacol Rev 1994;74:163-219.
17. Morelli E, Loon NR, Meyer TW, Peters W, Myers BD: Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990;39:76-82.
18. Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G, Remuzzi G: Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol 1993;6:36-43.
19. Myers BD, Guasch A: Mechanisms of massive proteinuria. J Nephrol 1994;7:254-260.
20. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-771.
21. Remuzzi A, Perico N, Amuchastegui CS, et al.: Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 1993;4:40-49.
22. Gansevoort RT, De Zeeuw D, De Jong PE: Is the anti-proteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system. Kidney Int 1994; 45:861-867.
23. Maack T: Physiological evaluation of the isolated perfused rat kidney. Am J Physiol 1980;238:F71-F78.
24. Burns KD, Homma T, Harris RC: The intrarenal renin-angiotensin system. Semin Nephrol 1993;13:13-30.
25. 1 subtype angiotensin II receptor antagonist. J Pharmacol Exp Ther 1993;265:826-834.
26. Perico N, Delaini F, Tagliaferri M, et al.: Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to protein in isolated perfused rat kidney. Lab Invest 1988;58:163-171.
27. Boyce NW, Holdsworth SR: Direct antiGBM antibody induced alterations in glomerular permselectivity. Kidney Int 1986;30:666-672.
28. Bradford M: A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-254.
29. Oliver JD, Anderson S, Troy JL, Brenner BM, Deen WM: Determination of glomerular size-selectivity in the normal rat with Ficoll. J Am Soc Nephrol 1992;3:214-228.
30. Scott TA, Melvin EH: Determination of dextran with anthrone. Anal Chem 1953;25:1656-1661.
31. Remuzzi A, Viberti G, Ruggenenti P, Battaglia C, Pagni R, Remuzzi G: Glomerular response to hyperglycemia in human diabetic nephropathy. Am J Physiol 1990;249: F374-F389.
32. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 1980; 47:1-9.
33. Addis T, Barrett E, Boyd RI, Ureen HJ: Renin proteinuria in the rat: I. The relation between the proteinuria and the pressor effect of renin. J Exp Med 1949;89:131-140.
34. Deodhar SD, Cuppage FE, Gableman E: Studies on the mechanism of experimental proteinuria induced by renin. J Exp Med 1964;120:677-690.
35. Eisenbach GM, Van Liew JB, Boylan JW: Effect of angiotensin on the filtration of protein in the rat kidney: a micropuncture study. Kidney Int 1975;8:80-87.
36. Bohrer MP, Deen WM, Robertson CR, Brenner BM: Mechanism of angiotensin II-induced proteinuria in the rat. Am J Physiol 1977;2:F13-F21.
37. Daniels BS, Deen WM, Meyer G, Meyer T, Hostetter TH: Glomerular permeability barrier in the rat: Functional assessment by in vitro methods. J Clin Invest 1993;92: 929-936.
38. Timple R, Wiedeman H, Van Delden V, Furthmayr H, Kuhn K: Network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981;120:203-211.
39. Perico N, Remuzzi A, Dadan J, Battaglia C, Remuzzi G: Platelet-activating factor alters glomerular barrier size selectivity for macromolecules in rats. Am J Physiol 1991;261:F85-F90.
40. Shake JG, Brandt RC, Daniels BS: Angiotensin II induces actin polymerization within the glomerular filtration barrier: possible role in the local regulation of Ultrafiltration [Abstract]. J Am Soc Nephrol 1992;3: 568A.
41. Oliver JD III, Simons JL, Troy JL, Provoost AP, Brenner BM, Deen WM: Proteinuria and impaired glomerular permselectivity in uninephrectomized fawn-hooded rats. Am J Physiol 1994;267:F917-F925.
42. Loon N, Shemesh O, Morelli E, Myers BD: Effect of angiotensin II infusion on the human glomerular filtration barrier. Am J Physiol 1989;257:F608-F614.
43. Bauman JW: On the mechanism of angiotensin-induced proteinuria. I. Studies in aminonucleoside nephrotic rats and in saralasin blockade. Nephron 1981;24:47-50.